Laura Forsberg White, PhD
Professor
Boston University School of Public Health
Biostatistics

PhD, Harvard University
BS, Utah State University



Laura Forsberg White, PhD, is a Professor of Biostatistics at Boston University and co-director of the graduate program in Biostatistics. She is the associate director of the Population Health Data Science Program and directs the Data Science and Surveillance Core of the Center for Emerging Infectious Diseases. Her research focuses on developing statistical tools to better understand the transmission dynamics and epidemiology of infectious diseases and substance use disorders. This includes the development of novel methodologies for the detection of disease outbreaks, as well as the application statistical methods for public health surveillance systems, including spatial statistics and time series. Dr. White's work includes applications and collaborations in Tuberculosis, Hepatitis C, HIV, and substance use disorders. She works with several large international studies focused on Tuberculosis, is part of the Boston Providence Center for AIDS Research, and a CDC CFA-funded Center of Excellence. She leads her own research group focused on developing statistical methods to better understand TB transmission and burden, as well as Covid-19 transmission dynamics. At SPH, she teaches Public Health Surveillance: A Methods Based Approach (BS 728).

Diversity, Equity, Inclusion and Accessibility

I chair our admissions committee and have participating in holistic admissions workshops. We have modified our processes to be more holistic and also to improve our outreach and support of students from historically underrepresented groups. I have participated in trainings on implicit bias and other topics related to DEIJ.

Adjunct Assistant Professor
Harvard T.H. Chan School of Public Health
Biostatistics




Researching Effective Strategies to Prevent Opioid Death (RESPOND)
09/15/2023 - 07/31/2028 (Multi-PI)
PI: Laura Forsberg White, PhD
Boston Medical Center Corporation NIH NIDA
2R01DA046527-06A1

BUSPH Interdisciplinary Training Program for Biostatisticians
07/01/2021 - 06/30/2026 (Multi-PI)
PI: Laura Forsberg White, PhD
NIH/National Institute of General Medical Sciences
5T32GM140972-03

Maximizing Investigator's Research Award (R35)
06/01/2021 - 05/31/2026 (PI)
NIH/National Institute of General Medical Sciences
5R35GM141821-03

Vertex Fellowship for Yuyan Liu
02/01/2024 - 12/31/2024 (PI)
Vertex Pharmaceuticals Incorporated


Vertex Fellowship for Jiaying Chen
09/01/2023 - 08/31/2024 (PI)
Vertex Pharmaceuticals Incorporated


Vertex Fellowship for Shiyao Li
09/01/2023 - 05/31/2024 (PI)
Vertex Pharmaceuticals Incorporated


Megan Willis (Student Research), Vertex Pharmaceuticals Incorporated
09/30/2022 - 12/31/2023 (PI)
Vertex Pharmaceuticals Incorporated


Tingting Xi (Student Research), Vertex Pharmaceuticals Incorporated
09/30/2022 - 09/29/2023 (PI)
Vertex Pharmaceuticals Incorporated


Researching Effective Strategies to Prevent Opioid Death (RESPOND)
06/01/2018 - 03/31/2023 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R01DA046527-05

Industry Engagement Techdata Corporation RAship for Siwen He
09/01/2020 - 09/01/2022 (PI)
TechData Service Company, LLC


Showing 10 of 19 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2024 Maximizing Investigators' Research Award (R35) 5R35GM141821-04
2023 BUSPH Interdisciplinary Training Program for Biostatisticians 5T32GM140972-03
2023 Maximizing Investigators' Research Award (R35) 5R35GM141821-03
2022 BUSPH Interdisciplinary Training Program for Biostatisticians 5T32GM140972-02
2022 Maximizing Investigators' Research Award (R35) 5R35GM141821-02
2021 BUSPH Interdisciplinary Training Program for Biostatisticians 1T32GM140972-01
2021 Maximizing Investigators' Research Award (R35) 1R35GM141821-01
2021 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-05 3
2020 Methods to Estimate the Effect of Interventions on the Incidence and Transmission of Tuberculosis 5R01GM122876-04 3
2020 Competitive revision to - Methods to estimate the effect of intervention on the incidence and transmission of Tuberculosis 3R01GM122876-04S1 3
Showing 10 of 15 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Wijk M, Gausi K, Malatesta S, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. J Antimicrob Chemother. 2024 Jul 10.View Related Profiles. PMID: 38985541
     
  2. Yamkovoy K, Patil P, Dunn D, Erdman E, Bernson D, Swathi PA, Nall SK, Zhang Y, Wang J, Brinkley-Rubinstein L, LeMasters KH, White LF, Barocas JA. Using decision tree models and comprehensive statewide data to predict opioid overdoses following prison release. Ann Epidemiol. 2024 Jun; 94:81-90.View Related Profiles. PMID: 38710239; PMCID: PMC11117432; DOI: 10.1016/j.annepidem.2024.04.011;
     
  3. Wang J, Bernson D, Erdman EA, Villani J, Chandler R, Kline D, White LF, Barocas JA. Intersectional inequities and longitudinal prevalence estimates of opioid use disorder in Massachusetts 2014-2020: a multi-sample capture-recapture analysis. Lancet Reg Health Am. 2024 Apr; 32:100709.View Related Profiles. PMID: 38510791; PMCID: PMC10951507; DOI: 10.1016/j.lana.2024.100709;
     
  4. Yamkovoy K, Self JL, Jenkins HE, Horsburgh CR, White LF. Patterns of TB transmission in the United States, 2011-2017. Int J Tuberc Lung Dis. 2024 Mar 01; 28(3):154-156.View Related Profiles. PMID: 38454181; PMCID: PMC11044277; DOI: 10.5588/ijtld.23.0422;
     
  5. Bayly H, Stoddard M, Van Egeren D, Murray EJ, Raifman J, Chakravarty A, White LF. Looking under the lamp-post: quantifying the performance of contact tracing in the United States during the SARS-CoV-2 pandemic. BMC Public Health. 2024 Feb 23; 24(1):595.View Related Profiles. PMID: 38395830; PMCID: PMC10893709; DOI: 10.1186/s12889-024-18012-z;
     
  6. Epstein RL, Buzzee B, White LF, Feld JJ, Castera L, Sterling RK, Linas BP, Taylor LE. Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus. J Viral Hepat. 2024 Jun; 31(6):277-292.View Related Profiles. PMID: 38326950; PMCID: PMC11102317; DOI: 10.1111/jvh.13925;
     
  7. Rodriguez CA, Horsburgh CR, Jenkins HE, White LF. Reply to 'Estimating TB survival - mind the immortal-time gap'. Int J Tuberc Lung Dis. 2024 Jan 01; 28(1):66-67.View Related Profiles. PMID: 38178287
     
  8. Bayly H, Mei W, Egeren D, Stoddard M, Chakravarty A, White LF. Accuracy of Inferences About the Reproductive Number and Superspreading Potential of SARS-CoV-2 with Incomplete Contact Tracing Data. Res Sq. 2023 Dec 29. PMID: 38234843; PMCID: PMC10793487; DOI: 10.21203/rs.3.rs-3760127/v1;
     
  9. Albright C, Van Egeren D, Thakur A, Chakravarty A, White LF, Stoddard M. Antibody escape, the risk of serotype formation, and rapid immune waning: Modeling the implications of SARS-CoV-2 immune evasion. PLoS One. 2023; 18(10):e0292099. PMID: 37851632; PMCID: PMC10584102; DOI: 10.1371/journal.pone.0292099;
     
  10. Tilhou AS, Murray E, Wang J, Linas BP, White L, Samet JH, LaRochelle M. Trends in buprenorphine dosage and days supplied for new treatment episodes for opioid use disorder, 2010-2019. Drug Alcohol Depend. 2023 Nov 01; 252:110981.View Related Profiles. PMID: 37839942; PMCID: PMC10615721; DOI: 10.1016/j.drugalcdep.2023.110981;
     
Showing 10 of 176 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 176 publications over 23 distinct years, with a maximum of 24 publications in 2021

YearPublications
19931
20032
20042
20052
20061
20072
20084
20097
20101
20116
20128
20139
20145
20157
201612
201713
20187
201912
202013
202124
202217
202314
20247
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Biostatistics
Infectious Diseases
infectious Disease Epidemiology
Public Health Surveillance
Tuberculosis
Substance Use Disorders
SARS-CoV-2

I am an experienced mentor of clinical fellows, postdoctoral fellows, PhD students and masters students. I work collaboratively with clinician scientists and provide expertise in statistical modeling, design of studies, and interpretation and dissemination of results. I am committed to meeting mentees where they are and helping them accomplish their personal goals and work through obstacles that they face in their career. I am passionate about seeing the whole person and recognizing the need to strive for appropriate work/life balance.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


White's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department